Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “All Types of Pediatric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04225676
What this trial is testing

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Not applicableStudy completedNCT05939791
What this trial is testing

Physical Exercise and Dairy Probiotics in Childhood Cancer Survivors

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Comenius University 29
Early research (Phase 1)Ended earlyNCT01066468
What this trial is testing

Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
Novartis Pharmaceuticals 3
Not applicableStudy completedNCT05992246
What this trial is testing

The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

Who this might be right for
Pediatric ALLFluid Overload
Tanta University 85
Testing effectiveness (Phase 2)Ended earlyNCT00941928
What this trial is testing

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
LeukemiaPediatric Cancer
M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT06649253
What this trial is testing

Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse

Who this might be right for
Leukemia, Lymphoblastic, Acute, Pediatric
Rennes University Hospital 50
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT05933811
What this trial is testing

Contralateral Testicular Volume in Unilateral Impalpable Testis

Who this might be right for
Pediatric ALL
Egyptian Biomedical Research Network 76
Not applicableLooking for participantsNCT06861530
What this trial is testing

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

Who this might be right for
Adrenal InsufficiencyLeukemia, Lymphoblastic, Acute, PediatricLymphoma, Lymphoblastic
University Children's Hospital Basel 40
Not applicableUnknownNCT03494998
What this trial is testing

Refining and Testing the Diagnostic Accuracy of PAT-POPS

Who this might be right for
Pediatric ALL
Pennine Acute Hospitals NHS Trust 80,000
Early research (Phase 1)Temporarily pausedNCT00077493
What this trial is testing

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 95
Early research (Phase 1)Ended earlyNCT01743807
What this trial is testing

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Who this might be right for
Relapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 4
Post-approval studies (Phase 4)Ended earlyNCT02618109
What this trial is testing

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaLeukemia Relapse
University Hospital, Angers 119
Early research (Phase 1)Study completedNCT00020111
What this trial is testing

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Not applicableStudy completedNCT06489236
What this trial is testing

Effectiveness of an Intervention on Vaccine Hesitancy Among Pediatric Nurses and Pediatricians

Who this might be right for
Vaccination HesitancyPediatric ALLPresumptive Communication+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 142
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05667506
What this trial is testing

CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 47
Not applicableStudy completedNCT04399863
What this trial is testing

ETOILE : A Feasibility Study in Pediatric Patient Education

Who this might be right for
Leukemia, Lymphoblastic
Assistance Publique - Hôpitaux de Paris 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02028455
What this trial is testing

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
CD19+ Acute Leukemia
Seattle Children's Hospital 167
Next Page